Percutaneous radiofrequency ablation of painful osseous metastases: A multicenter American College of Radiology Imaging Network trial

Cancer

Volumn 116, Issue 4, 2010, Pages 989-997

  Dupuy, Damian E ^a   Liu, Dawei ^b,c   Hartfeil, Donna ^d   Hanna, Lucy ^b   Blume, Jeffrey D ^b,e   Ahrar, Kamran ^f   Lopez, Robert ^g   Safran, Howard ^a   Dipetrillo, Thomas ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d AMERICAN COLLEGE OF RADIOLOGY   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g University of Alabama at Birmingham   (United States)

Author keywords

Bone metastases; Pain palliation; Radiofrequency ablation; Tumor ablation

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PAIN ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE;

EID: 76249101391     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24837     Document Type: Article

References (36)

1. Stoll BA, Parbhoo S (eds). Bone Metastasis: Monitoring and Treatment. New York, NY: Raven Press; 1983.
2. Twycross RG. Management of pain in skeletal metastases. Clin Orthop Relat Res. 1995;312:187-196.
3. Janjan NA. Radiation for bone metastases: conventional techniques and the role of systemic pharmaceuticals. Cancer. 1997;80:1628-1645.
4. Quilty PM, Kirk D, Bolger JJ, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol. 1994;31:33-40.
5. Serafini AN, Houston SJ, Resche I, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double blind placebo-controlled trial. J Clin Oncol. 1998;16:1574-1581.
6. Hortobagyi GB, Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med. 1999;12:1785-1791.
7. Conte PF, Latreille J, Mauriac L, et al. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group. J Clin Oncol. 1996;14:2552-2559.
8. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the radiation therapy oncology group. Cancer. 1982;50:893-899.
9. Madsen EL. Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4Gy versus 10Gy x 2. Int J Radiat Oncol Biol Phys. 1983;9:1775-1779.
10. Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer. 1984;55:1468-1472.
11. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986;6:247-255.
12. Arcangeli G, Micheli A, Arcangeli G, et al. The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol. 1989;14:95-101.
13. Cole DJ. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol. 1989;1:59-62.
14. Poulter CA, Cosmatos D, Rubin P, et al. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective that local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys. 1992;23:207-214.
15. Arcangeli G, Giovinazzo G, Saracino B, et al. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys. 1998;42:1119-1126.
16. Ratanatharathorn V, Powers WE, Moss WT, Perez CA. Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys. 1999;44:1-18.
17. Agarawal JP, Swangsilpa T, van der Linden Y, Rades D, Jeremic B, Hoskin PJ. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol). 2006;18:747-760.
18. Cleeland CS. The measurement of pain from metastatic bone disease: capturing the patient's experience. Clin Cancer Res. 2006;12:6236s-6242s.
19. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT and USguided radio-frequency ablation. Radiology. 2002;224:87-97.
20. Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multi-center study. J Clin Oncol. 2004;22:300-306.
21. Fishman B, Pasternak S, Wallenstein SL, House RW, Holland JC, Foley KM. The memorial pain assessment card. A valid instrument for the evaluation of cancer pain. Cancer. 1987;60:1151-1158.
22. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 2002.
23. Hedeker D, Gibbons RD. Application of random-effects pattern mixture models for missing data in longitudinal studies. Psychol Methods. 1997;2:64-78.
24. Gangi A, Kastler BA, Klinkert A, Dietemann JL. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomogr. 1994;18:932-935.
25. Levine SA, Perin LA, Hayes D, Hayes WS. An evidence-based evaluation of percutaneous vertebroplasty. Manag Care. 2000;9:56-60, 63.
26. Dupuy DE, Hong RJ, Oliver B, Goldberg SN. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. Am J Roentgenol. 2000;175:1263-1266.
27. Rosenthal DI, Hornicek FJ, Wolf MW, Jennings LC, Gebhardt MC, Mankin HJ. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am. 1998;80:815-821.
28. Sweet WH, Wepsic JG. Controlled thermocoagulation of trigeminal ganglion and rootlets for differential destruction of pain fibers. J Neurosurg. 1974;40:143-156.
29. Sluijter ME. The use of radiofrequency lesions for pain relief in failed back patients. Int Disabil Studies. 1988;10: 37-43.
30. Ogsbury JS, Simons H, Lehman RAW. Facet denervation in treatment of low back syndrome. Pain. 1977;2:257-263.
31. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK Pandya KJ. Physician attitudes and practice in cancer pain management: a survey from the eastern cooperative oncology group. Ann Intern Med. 1993;119:121-126.
32. Moryl N, Coyle N, Foley KM. Managing an acute pain crisis in a patient with advanced cancer: this is as much of a crisis as a code. JAMA. 2008;299:1457-1467.
33. Kutner JS, Smith MC, Corbin L, et al. Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial. Ann Intern Med. 2008;149:369-379.
34. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97: 798-804.
35. Agresti A. An Introduction to Categorical Data Analysis. New York, NY: John Wiley & Sons; 2007.
36. Grieco CA, Simon CJ, Mayo-Smith WW, Dipetrillo TA, Ready NE, Dupuy DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol. 2007;30:361-367.